The results of this study support health warnings that there is no safe level of exposure to tobacco smoke, said Maki Inoue-Choi, Ph.D., NCI, Division of Cancer Epidemiology and Genetics, and lead author of the study
The working group rated outcomes according to GRADE.21 Outcomes rated as critical or important by focus group participants (described below) and working group members were considered during guideline development
Davis anticipates that future evidence may emerge showing that VLNC cigarettes can be used alone or in conjunction with existing FDA-approved smoking cessation treatments and facilitate smoking cessation
Bittoni, PhD, MS , research assistant professor at The Ohio State University Comprehensive Cancer Center Arthur G
Funding This work was supported by grants from the National Cancer Institute (U54CA229973) and the Office of the Director (DP5OD023064) of the National Institutes of Health (NIH)